How to Handle Constipation on Compounded Semaglutide or Tirzepatide
Written by: GobyMeds Editorial Team
Constipation is one of the more frustrating side effects people run into on GLP-1 medications.
It is not always the most talked-about one. Nausea gets more attention. So does vomiting. But for many patients on compounded semaglutide or compounded tirzepatide, constipation is the side effect that quietly makes everyday life more uncomfortable.
You may feel:
- backed up
- bloated
- uncomfortable after meals
- like you are not fully emptying
- like your digestion suddenly got much slower
If that sounds familiar, you are not imagining it.
Constipation is listed among the common adverse reactions with both semaglutide and tirzepatide products.[1][2] In adult weight-reduction trials with WEGOVY 2.4 mg injection, constipation was reported in 24% of semaglutide-treated patients versus 11% on placebo.[1] In pooled weight-reduction trials with ZEPBOUND, constipation was reported in 17%, 14%, and 11% of patients on 5 mg, 10 mg, and 15 mg tirzepatide, respectively, versus 5% on placebo.[2]
So yes, this is common.
The good news is that in many cases, constipation can be managed. The key is to address it early, stay practical, and know when it is just an annoying side effect versus when it is a sign that your dose or your overall plan needs more attention.

Why GLP-1s Can Cause Constipation
Semaglutide and tirzepatide both delay gastric emptying.[1][2] In plain language, they slow how quickly food moves through the digestive system.
That is part of why these medications can help with appetite and weight loss.
It is also part of why some people feel:
- fuller longer
- less hungry
- more easily bloated
- more constipated
For tirzepatide specifically, the prescribing information notes that the delay in gastric emptying is largest after the first dose and tends to diminish over time.[2] That helps explain why some people notice digestive side effects most during the early weeks or after dose increases.
With compounded semaglutide and compounded tirzepatide, the side-effect pattern is often similar because the active medication is still working in the GLP-1 pathway. Compounded semaglutide and compounded tirzepatide are not FDA-approved products, but the FDA notes that many reported adverse events with compounded versions appear consistent with the adverse events seen with FDA-approved versions of these drugs.[3]
Constipation on Compounded GLP-1s Is Not Always Just About the Drug
The medication is a big factor, but it is not the only factor.
Constipation can get worse on compounded semaglutide or tirzepatide because many patients are also:
- eating less overall
- drinking less water
- moving less because they feel off
- increasing dose too quickly
- unsure whether they are actually drawing up the right dose
That last point matters.
The FDA has specifically warned about dosing errors with compounded injectable semaglutide and notes that some of the reported symptoms have included nausea, vomiting, diarrhea, abdominal pain, and constipation.[3] With compounded products, patients may need to measure doses from a vial rather than use a prefilled branded pen, which creates more room for confusion if instructions are not crystal clear.[3]
So if your constipation suddenly got much worse after a dose change, or if you are not fully confident you are measuring the right amount, that is not something to brush off.
What Usually Helps First
For most people, the first steps are not dramatic. They are basic, but they matter.
1. Increase fluids
If you are constipated, hydration is one of the first things to look at.
The National Institute of Diabetes and Digestive and Kidney Diseases recommends drinking plenty of liquids to help fiber work better and make stools softer and easier to pass.[4][5]
This is especially relevant on a GLP-1 because people often eat less and drink less without realizing it.
A simple question to ask yourself is:
Have I actually been drinking enough, or have I just assumed I am?
If your intake has dropped, fluids may be part of the problem.
2. Add fiber, but not aggressively
Fiber can help, but this is where people sometimes overcorrect.
NIDDK recommends eating enough fiber and adding it gradually so your body gets used to the change.[4][5] Good sources include whole grains, legumes, fruits like apples and pears with the skin on, vegetables like carrots and broccoli, and nuts.[4]
That said, if you are already feeling very bloated and backed up, suddenly dumping a huge amount of fiber into your diet can make you feel worse before it makes you feel better.
A better approach is:
- add fiber slowly
- pair it with fluids
- use whole-food sources when possible
- avoid turning it into an overnight project
3. Move your body
Regular physical activity may help relieve constipation symptoms.[6]
You do not need an extreme workout plan for this to matter. Walking, light movement, and keeping your body moving through the day can all help support better bowel function.
This is especially useful if GLP-1 side effects have made you more sedentary than usual.
4. Do not ignore the urge to go
NIDDK also recommends giving yourself enough time for a bowel movement and going when you feel the need instead of consistently putting it off.[6]
This sounds simple, but it is easy to ignore when life gets busy. On a GLP-1, your digestive system may already be moving more slowly. Delaying bathroom time can make things even more frustrating.
5. Consider whether your dose increase was too much, too fast
This is one of the biggest GLP-1-specific questions.
Both semaglutide and tirzepatide labeling emphasize dose escalation to reduce gastrointestinal adverse reactions.[1][2] WEGOVY’s prescribing information says that if patients do not tolerate a dose during escalation, delaying dose escalation for 4 weeks should be considered.[1] ZEPBOUND’s prescribing information says to consider a lower maintenance dose if the patient does not tolerate the maintenance dose.[2]
That matters clinically.
If your constipation significantly worsened right after a dose increase, the answer may not be “push through no matter what.” It may be that the pace or dose needs a second look.

Over-the-Counter Constipation Options: Sometimes Helpful, but Best Used Intentionally
If food, fluids, movement, and time are not enough, over-the-counter support may be worth discussing with your clinician.
NIDDK notes that a healthcare professional may recommend short-term use of:
- fiber supplements
- osmotic agents such as polyethylene glycol
- stool softeners
- stimulant laxatives, especially if constipation is severe or other options have not worked[6]
That does not mean everyone on a GLP-1 should automatically start taking multiple constipation products on their own.
It means constipation management can include short-term tools when lifestyle steps are not enough.
The smartest move is usually to ask:
What is the best next step for my situation?
instead of:
What can I take all at once?
When Constipation May Mean the Plan Needs to Change
Sometimes constipation is manageable and temporary.
Sometimes it is a sign that your current treatment plan needs adjustment.
That conversation becomes more important if:
- constipation keeps worsening with each dose increase
- you are needing more rescue products just to function
- bloating and abdominal discomfort are becoming a pattern
- your intake is so low that digestion seems to be stalling
- you are not sure your compounded dose is being measured correctly
This is especially important with compounded products, because dose concentration and volume can vary by pharmacy. If instructions are unclear, the risk of getting the wrong amount goes up.[3]
If you are constipated and also unsure whether your units, milliliters, or syringe markings are correct, pause and get clarification. Do not guess.
When to Call Your Clinician Right Away
Not all constipation should be handled at home.
NIDDK recommends seeing a doctor right away if constipation comes with any of the following:[7]
- bleeding from the rectum
- blood in the stool
- constant abdominal pain
- inability to pass gas
- vomiting
- fever
- lower back pain
- unintentional weight loss
This matters even more on a GLP-1 because semaglutide and tirzepatide labels both warn about severe gastrointestinal adverse reactions, and both products are not recommended in patients with severe gastroparesis.[1][2]
There are also postmarketing reports with tirzepatide that include severe constipation, fecal impaction, and intestinal obstruction, while semaglutide labeling also warns about severe gastrointestinal adverse reactions more broadly.[1][2]
So if your symptoms are severe, persistent, or starting to feel like more than “just constipation,” do not wait it out indefinitely.
Does This Mean the Medication Is Not Right for You?
Not necessarily.
Many people have some constipation early on and improve with:
- better hydration
- a slower increase in fiber
- more movement
- a dose adjustment
- time at the same dose
But if constipation is making the medication hard to tolerate, that is still clinically important.
A treatment only works if you can stay on it safely and comfortably enough for it to be useful.
That is why side-effect management is not separate from treatment. It is part of treatment.
Where GobyMeds Fits In
If you are using compounded semaglutide or compounded tirzepatide, constipation should not be treated like a minor detail you are expected to just figure out alone.
This is exactly where good clinician-guided care matters.
The right response may be:
- staying at your current dose longer
- checking whether your compounded dose instructions are correct
- tightening up fluids and fiber
- using short-term constipation support appropriately
- deciding whether the medication or titration pace needs to change
At GobyMeds, the goal is not just access to medication. It is helping patients stay on a plan that is tolerable, understandable, and realistic.
e

The Bottom Line
Constipation is a common side effect on compounded semaglutide and compounded tirzepatide, and in many cases it can be managed.
The first steps are usually practical:
- drink more fluids
- increase fiber gradually
- move regularly
- give yourself time to go
- do not ignore worsening symptoms after a dose increase
If those steps are not enough, it may be time to talk with your clinician about short-term constipation support, a slower titration plan, or a lower dose.
And if you have severe abdominal pain, vomiting, bleeding, or cannot pass gas, do not try to self-manage that at home.
Constipation may be common on GLP-1s, but severe constipation deserves attention.
Ready to see if GLP-1s are a good fit for you? Starting the journey slowly and with the right support is how you can set yourself up for success. Click here to see if obyMeds is a good fit for you!
FAQ
Is constipation common on compounded semaglutide or compounded tirzepatide?
Yes. Constipation is a common side effect with semaglutide and tirzepatide products, and the FDA notes that many adverse events reported with compounded versions appear consistent with the FDA-approved versions.[1][2][3]
Why do GLP-1s cause constipation?
Semaglutide and tirzepatide delay gastric emptying, which slows digestion and can contribute to constipation in some patients.[1][2]
What should I try first if I am constipated on a compounded GLP-1?
Start with the basics: increase fluids, add fiber gradually, keep moving, and avoid ignoring the urge to have a bowel movement.[4][5][6]
Can I use over-the-counter constipation products?
Possibly, but it is best to use them intentionally. NIDDK notes that healthcare professionals may recommend short-term use of fiber supplements, osmotic agents, stool softeners, or stimulant laxatives depending on the situation.[6]
When should I call my clinician?
Reach out if constipation is getting worse, keeps coming back after dose increases, or if you are not confident your compounded dose is being measured correctly. Seek medical care right away if you have severe symptoms like vomiting, constant abdominal pain, inability to pass gas, bleeding, or blood in the stool.[3][7]
Footnotes
[1] U.S. Food and Drug Administration. WEGOVY (semaglutide) prescribing information. Revised March 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s029lbl.pdf
[2] U.S. Food and Drug Administration. ZEPBOUND (tirzepatide) prescribing information. Revised February 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s042lbl.pdf
[3] U.S. Food and Drug Administration. “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.” Updated June 11, 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
[4] National Institute of Diabetes and Digestive and Kidney Diseases. “Eating, Diet, & Nutrition for Constipation.” https://www.niddk.nih.gov/health-information/digestive-diseases/constipation/eating-diet-nutrition
[5] MedlinePlus. “Constipation.” https://medlineplus.gov/constipation.html
[6] National Institute of Diabetes and Digestive and Kidney Diseases. “Treatment for Constipation.” https://www.niddk.nih.gov/health-information/digestive-diseases/constipation/treatment
[7] National Institute of Diabetes and Digestive and Kidney Diseases. “Symptoms & Causes of Constipation.” https://www.niddk.nih.gov/health-information/digestive-diseases/constipation/symptoms-causes


